Aim ImmunoTech CEO Equels buys $5,093 of common stock
Aim ImmunoTech CEO Equels buys $5,093 of common stock
Not thousands of headlines. The few lines that move price. For traders: straight from the source, clear and simple.
Aim ImmunoTech CEO Equels buys $5,093 of common stock
Tyler Robinson requests 2029 trial for alleged murder of Charlie Kirk
OptionMetrics flags hidden gems in commodities as wheat, soybeans outshine copper
US telecom operators wobble after report SpaceX in talks for cell sites
Stocks mixed, day after AI-related selloff; oil prices rise again
US fines Air France, KLM over flights in prohibited Iraqi airspace
Store aisles are getting a digital makeover.
Lycia Therapeutics surges in debut following upsized $317.5M IPO
First Quantum readies Argentina tax-break plans for $5.3 billion Taca Taca copper project
New York City bans horse-drawn carriages from June 2028
Why is Palo Alto Networks stock surging today?
Brent crude nears $120 as escalating Saudi-Houthi tensions fuel another weekly oil price rally, putting fresh pressure on Trump. Friday, October 23, 2026 The slow creep of oil prices towards the $120 per barrel mark is a nightmarish scenario for US President Trump, even though there has been little fundamental change in the crude oil markets. A slight drop in freight rates and a ubiquitous…
Why is Check Point Software stock rallying today?
Why is SentinelOne stock rallying today?
Why is Okta stock surging today?
The SEC’s latest priorities highlight tokenization as an emerging market risk, while cryptocurrencies remain absent as a standalone examination category.
Balchem Q3 2026 slides: record quarter, 29th straight EBITDA gain
Eni ADR earnings beat by $0.25, revenue topped estimates
Western Digital earnings analysis: questions answered and next catalysts
Rubrik stock hits all-time high at 127.94 USD
News text belongs to its source; only the headline and a short summary appear here.